.png){kind=icon}
.png){kind=icon}
Return
Evaluation of an Immune-guided Prevention Strategy Against CMV Among Intermediate-risk Kidney Transplant Recipients: A Quasi-experimental Study
.png){kind=icon}
PRE
AI
J
F
G
P
N
T
S
A
P
A
L
J
R
DOI：10.1097/TP.0000000000005694.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Observational studies have shown that kidney transplant (KT) recipients who are cytomegalovirus (CMV)-seropositive (R+) but lack effective CMV-specific cell-mediated immunity (CMV-CMI) are at increased risk of CMV infection.
Journal
IF:
5
Papers:
2.8W
Citations:
2.3W
Organization
Cited Papers